Replies to post #615 on Bio-AMD Inc. (fka BIAD)

[514]

I get your point now. Sounds less bashy. Your point remains. And yes refutable, not meaning your are not right. Again.. Chart.. Hourly is hot.. Still tradeable, hard these days to find an Otc stock with a steady uptrend.. Otc attracts flippers.. So? If someone wants to sell at 20% 30% 50% 200% so be it.. I don't see any pump just posters happy to have found something that looks different. And I believe it is. Basing points on past trades and different tickers is useless imo, I concentrate on BIAD. If you hate shareholders getting stuck, you gonna have to post that on every single otc ticker on ihub. We just believe this has more upside than any others. People don't have to buy it as it's low volume trading and could get volatile. Amd having a new IR firm just means more eyes and volume. We agree on that. Another point, I'm sure you'll agree.. Not to long ago this stock was trading in the teens level and below, obvious that at some point peeps will sell to ride free.. As you can simply see on the chart, record volume came in this week, at the highest of levels.. And it's holding up.. The fundamentals don't point to new investors with a lot more shares to sell for a loss... Jmo, logic...

[BiotechValues]

Hi value1008

My 2 cents is:

-Liquidity will remain pretty healthy going forward due to forward events.

-Yes, I received some $ from BIAD's IR firm for the article. But I've also purchased shares in the open market (as high as .22) and will continue to do so on pullbacks because I personally believe in the company after having spoken with management during my due diligence.

-I can't speak for anyone else, but I'm here for the long haul myself. Will some flip for a quick profit? Absolutely... and there's nothing wrong with that. Some will flip for a penny. Others will flip for a dime, others will hold for a 6-12 month period or more, some might sell half after a nice gain and hold the rest, etc. Everyone's different.

But the bottom line (in my opinion) is that liquidity will remain healthy overall as there are several positive forward events to come, and I also believe the company will be making more of an effort to put out press releases/keep current and new investors aware of progress, etc. This belief is based on the conversation I had with the CEO, Tom Barr. I expect liquidity will remain decent for some time, and unless you're looking to sell in a week, who cares really about liquidity? I'm here for commercialization (via Sysmex, or some other biotech giant) of the COAG and MIDS systems...and that's not going to happen in a week or two anyway.